This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
DeFrancesco, L., Subbaraman, N. Sequencing firms eye pathology labs as next big market opportunity. Nat Biotechnol 29, 379–380 (2011). https://doi.org/10.1038/nbt0511-379
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0511-379
This article is cited by
-
Direct-to-consumer genomics reinvents itself
Nature Biotechnology (2012)